Decentralized Clinical Trials: Technology Infrastructure & Regulatory Pathway
Description
Strategic analysis of decentralized & distributed clinical trial infrastructure. FDA C3TI and EMA ACT EU programs advancing digital standards. Covers wearables, remote monitoring, blockchain, and regulatory acceptance frameworks.
Table of Contents
65 Pages
- EXECUTIVE SUMMARY
- 1.1 Decentralized Trial Landscape
- 1.2 Regulatory Acceleration Programs
- 2.0 TECHNOLOGY INFRASTRUCTURE
- 2.1 Home-Based Testing Equipment
- 2.2 Wearable Device Integration
- 2.3 Remote Patient Monitoring Platforms
- 3.0 DATA MANAGEMENT
- 3.1 Real-Time Data Capture
- 3.2 Blockchain for Data Integrity
- 3.3 Privacy & Security Protocols
- 4.0 REGULATORY STRATEGY
- 4.1 FDA C3TI Framework
- 4.2 EMA ACT EU Program
- 4.3 Regulatory Submission Strategy
- 5.0 IMPLEMENTATION APPROACH
- 5.1 Technology Partner Selection
- 5.2 Patient Recruitment Strategy
- 5.3 Cost-Benefit Analysis
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.



